NCT05663931Active, not recruiting
Diabetes Toolkit at Discharge
Implementation and Testing of a Diabetes Discharge Intervention to Improve Safety During Transitions of Care
Source: ClinicalTrials.gov · Last updated 23 Oct 2026
Brief summary (registry, in English)
The purpose of this randomized clinical trial is to implement the DM Discharge Toolkit into hospital discharge and assess the effect of the DM Discharge Toolkit on patients newly requiring insulin.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 17 Nov 2022
- Start date
- 20 Aug 2024
- Primary completion date
- 1 May 2026
- Lead sponsor
- Northwestern University
- Diseases
- Type 1 diabetes, Type 2 diabetes
- NCT number
- NCT05663931
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 20 Aug 2024 to the primary completion date, 1 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Not diagnosed with diabetes
Other
- Patients with the inability to give informed consent
- Non-English speaking
- Not been newly prescribed insulin
Who the study is looking for
- English speaking patients
- 18 years of age and older
- Expected survival \>90 days
- Need for new insulin at time of hospital discharge
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Northwestern Memorial Hospital Coordinator of this site? Confirm its status | Chicago | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.